NEW YORK, May 9, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), an innovative, clinical-stage biopharmaceutical company, today announced that a conference call will be held on Tuesday, May 13, 2014 at 8:30 a.m. ET to discuss results for the first quarter of 2014 and provide a business outlook for the remainder of 2014. Michael Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.
Help employers find you! Check out all the jobs and post your resume.
